These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 1319088

  • 1. Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy carboplatin, etoposide, and epirubicin.
    Collard P, Weynants P, Francis C, Rodenstein DO.
    Thorax; 1992 May; 47(5):369-71. PubMed ID: 1319088
    [Abstract] [Full Text] [Related]

  • 2. Treatment of relapse of small cell lung cancer in selected patients with the initial combination chemotherapy with carboplatin, etoposide and epirubicin.
    Nyman CR.
    Thorax; 1992 Aug; 47(8):668. PubMed ID: 1329248
    [No Abstract] [Full Text] [Related]

  • 3. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
    Sundstrøm S, Bremnes RM, Kaasa S, Aasebø U, Aamdal S, Norwegian Lung Cancer Study Group.
    Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
    [Abstract] [Full Text] [Related]

  • 4. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Frommhold H, Pressler K, Mertelsmann R, Kanz L.
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC, McCrystal MR, Christmas TI.
    N Z Med J; 1998 Nov 27; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [Abstract] [Full Text] [Related]

  • 6. Carboplatin in association with etoposide and either adriamycin or epirubicin for untreated small cell lung cancer: a dose escalation study of carboplatin. UCL Clinical Oncology Group.
    Humblet Y, Weynants P, Bosly A, Majois F, Duprez P, Francis C, Beauduin M, Machiels J, Gailly C, Delaunois L.
    Med Oncol Tumor Pharmacother; 1989 Nov 27; 6(3):207-12. PubMed ID: 2559261
    [Abstract] [Full Text] [Related]

  • 7. Carboplatin, epirubicin, and VP-16 chemotherapy in the treatment of small cell lung cancer.
    Gridelli C, Ianniello GP, Maiorino A, Curcio C, D'Aprile M, Brancaccio L, Palmeri S, Gentile M, Comella G, Pedicini T.
    Am J Clin Oncol; 1994 Apr 27; 17(2):160-2. PubMed ID: 8141108
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer.
    Gridelli C, Perrone F, D'Aprile M, Rossi A, Palmeri S, Curcio C, Veltri E, Ianniello G, Lorusso V, Palmieri G.
    Eur J Cancer; 1995 Dec 27; 31A(13-14):2424-6. PubMed ID: 8652288
    [No Abstract] [Full Text] [Related]

  • 9. Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
    Gridelli C, Curcio C, Iaffaioli RV, Brancaccio L, D'Aprile M, Gebbia V, Rossi A, Tortoriello A, Veltri E, Maione P, Barbarisi A, Gallo C, Guida C, Perrone F.
    Anticancer Res; 2001 Dec 27; 21(6A):4179-83. PubMed ID: 11911315
    [Abstract] [Full Text] [Related]

  • 10. Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.
    Prendiville J, Radford J, Thatcher N, Steward W, Ranson M, Burt P, Stout R.
    J Clin Oncol; 1991 Aug 27; 9(8):1446-52. PubMed ID: 1649266
    [Abstract] [Full Text] [Related]

  • 11. Carboplatin/etoposide/vincristine therapy in small cell lung cancer.
    Gatzemeier U, von Pawel J, Laumen R, Hossfeld DK, Neuhauss R, Reck M, Lenaz L.
    Oncology; 1992 Aug 27; 49 Suppl 1():25-33. PubMed ID: 1323809
    [Abstract] [Full Text] [Related]

  • 12. A randomized study of etoposide and carboplatin with or without paclitaxel in the treatment of small cell lung cancer.
    Birch R, Weaver CH, Hainsworth JD, Bobo C, Greco FA.
    Semin Oncol; 1997 Aug 27; 24(4 Suppl 12):S12-135-S12-137. PubMed ID: 9331138
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysis.
    Strauss GM, Lynch TJ, Elias AD, Jacobs C, Herbst R, Leong T, Lynch C, Kwiatkowski DJ, Carey RW, Grossbard ML, Skarin AT.
    Semin Oncol; 1997 Aug 27; 24(4 Suppl 12):S12-73-S12-80. PubMed ID: 9331127
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Carboplatin/etoposide in small cell lung cancer.
    Bishop JF.
    Oncology; 1992 Aug 27; 49 Suppl 1():11-7; discussion 17-8. PubMed ID: 1323807
    [Abstract] [Full Text] [Related]

  • 17. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD, Gray JR, Stroup SL, Kalman LA, Patten JE, Hopkins LG, Thomas M, Greco FA.
    J Clin Oncol; 1997 Dec 27; 15(12):3464-70. PubMed ID: 9396399
    [Abstract] [Full Text] [Related]

  • 18. Phase II trial of cisplatin/etoposide and concurrent radiotherapy followed by paclitaxel/carboplatin consolidation for limited small-cell lung cancer: Southwest Oncology Group 9713.
    Edelman MJ, Chansky K, Gaspar LE, Leigh B, Weiss GR, Taylor SA, Crowley J, Livingston R, Gandara DR.
    J Clin Oncol; 2004 Jan 01; 22(1):127-32. PubMed ID: 14701775
    [Abstract] [Full Text] [Related]

  • 19. [Chemotherapy in extended small-cell lung cancer. Retrospective analysis of two different series of patients treated with carboplatin and etoposide or ciclophosphamide-epidoxorubicin and etoposide].
    Tassinari D, Genestreti G, Pasquini E, Fantini M, Poggi B, Tamburini E, Papi M, Ioli G, Oliverio G, Fochessati F, Arcangeli V, Agostini V, Mianulli AM, Imola M, Fattori PP, Ravaioli A.
    Recenti Prog Med; 2005 May 01; 96(5):234-9. PubMed ID: 15977652
    [Abstract] [Full Text] [Related]

  • 20. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
    Hainsworth JD, Stroup SL, Greco FA.
    Cancer; 1996 Jun 15; 77(12):2458-63. PubMed ID: 8640693
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.